Brief: Evolus Announces Results From European Head-To-Head Filler Trial

Evolus

01/03/2024 13:35

March 1 (Reuters) - Evolus Inc  EOLS.O :
    * EVOLUS ANNOUNCES RESULTS FROM EUROPEAN HEAD-TO-HEAD FILLER
TRIAL
    * EVOLUS INC - EUROPEAN LIFT STUDY MET PRIMARY ENDPOINT OF
NON-INFERIORITY
    * EVOLUS INC - LIFT IS CE MARKED IN EUROPE AND WILL BE FILED
WITH
FDA IN SUMMER OF 2024 WITH APPROVAL EXPECTED IN 2025

Source text for Eikon:  ID:nBw4cKhHSa 
Further company coverage:  EOLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))